Viewing Study NCT05810961


Ignite Creation Date: 2025-12-24 @ 11:49 AM
Ignite Modification Date: 2026-01-01 @ 3:02 AM
Study NCT ID: NCT05810961
Status: TERMINATED
Last Update Posted: 2024-11-22
First Post: 2023-03-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014)
Sponsor: argenx
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module